Candesartan for Treatment of Migraine Headache: A Scoping Review
Abstract
PURPOSE: Migraine is a prevalent and debilitating disorder, ranked as the third leading cause of global disability. Given its significant health and financial impact, exploring alternative treatments is crucial. Candesartan, an angiotensin-receptor blocker, has shown potential as a management for migraine.
METHODS: A scoping review of literature on the efficacy and safety of candesartan in migraine treatment was performed based on the Preferred Reporting Items for Systematic Reviews and Meta-Analysis for Scoping Reviews guidelines.
FINDINGS: Thirty-eight articles were included in this review. Candesartan has shown promising results in preventing migraine, particularly in patients with comorbid conditions such as hypertension. Its mechanism may involve modulation of the central pain pathway and vascular functions. Clinical studies support its efficacy in reducing headache days, migraine hours, and related disability, with results comparable to those of established migraine treatments such as beta-blockers. Candesartan's favorable cost profile, once-daily dosing, and good tolerability further support its potential as a first-line treatment option.
IMPLICATIONS: Candesartan offers a promising addition as an effective and safe option for migraine treatment, but further research is necessary. Future studies should focus on its use for acute attacks, dose-response relationships, long-term safety, and cost-effectiveness.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.